Removab

Medicinal product

(Invented) name

Removab

Active substance (s)

Katumaksomabas

Strength

50 µg

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į pilvaplėvės ertmę

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX03, catumaxomab

Marketing authorisation holder

Neovii Biotech GmbH, Vokietija

Date of authorisation

2009-04-20

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	0.5 ml
Katumaksomabas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
34891	37231	1037231	užpildytas švirkštas	N1+1 kaniulė		Receptinis	EU/1/09/512/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-06-07	Išregistruotas
2009-04-20	Registruotas